Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transcutaneous Electrical Acupoint Stimulation vs Dexamethasone for Prophylaxis of Postoperative Nausea and Vomiting in Mastectomy
ChiCTR2200061377Phase 4Not yet recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Incidence of nausea and vomiting within 24 hours after surgery. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2200061377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061377.